STRATA Skin Sciences Files 8-K on Financials

TL;DR

STRATA Skin Sciences dropped an 8-K detailing financial results and exhibits.

AI Summary

STRATA Skin Sciences, Inc. filed an 8-K on August 13, 2025, reporting on its results of operations and financial condition. The filing also included Regulation FD disclosures and financial statements and exhibits. The company, formerly known as MELA SCIENCES, INC. and ELECTRO OPTICAL SCIENCES INC, is incorporated in Delaware and headquartered in Horsham, Pennsylvania.

Why It Matters

This 8-K filing provides investors with crucial updates on STRATA Skin Sciences' financial performance and operational status, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine 8-K filing for financial reporting and does not indicate any immediate or significant new risks.

Key Players & Entities

• STRATA Skin Sciences, Inc. (company) — Registrant
• MELA SCIENCES, INC. (company) — Former Company Name
• ELECTRO OPTICAL SCIENCES INC (company) — Former Company Name
• August 13, 2025 (date) — Date of Report
• Delaware (jurisdiction) — State of Incorporation
• Horsham, Pennsylvania (location) — Principal Executive Offices

FAQ

Key Financial Figures

• $0.001 — ange on which registered Common Stock, $0.001 par value per share SSKN The NASDAQ

Filing Documents

• ef20053890_8k.htm (8-K) — 28KB
• ef20053890_ex99-1.htm (EX-99.1) — 312KB
• image00001.jpg (GRAPHIC) — 3KB
• 0001140361-25-030853.txt ( ) — 494KB
• sskn-20250813.xsd (EX-101.SCH) — 4KB
• sskn-20250813_lab.xml (EX-101.LAB) — 21KB
• sskn-20250813_pre.xml (EX-101.PRE) — 16KB
• ef20053890_8k_htm.xml (XML) — 4KB

02

Item 2.02. Results of Operations and Financial Condition. On August 13, 2025, STRATA Skin Sciences, Inc. (the "Company") issued a press release announcing its results of operations for the second fiscal quarter ended June 30, 2025 . The full text of such press release is furnished as Exhibit 99.1 to this report. The information set forth under this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

01

Item 7.01. Regulation FD Disclosure. On August 13, 2025, STRATA Skin Sciences, Inc. (the "Company") issued a press release announcing its results of operations for the second fiscal quarter ended June 30, 2025. The full text of such press release is furnished as Exhibit 99.1 to this report. The information set forth under this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. The following press release is furnished as an exhibit to this Current Report on Form 8-K pursuant to Item 2.02 and shall not be deemed to be "filed": 99.1 Press Release dated August 13, 2025 issued by STRATA Skin Sciences, Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STRATA SKIN SCIENCES, INC. Date: August 13, 2025 By: /s/ John Gillings Chief Accounting Officer -3-

View Full Filing

View this 8-K filing on SEC EDGAR